IGHE and Alzheimer disease: Although various antibody drugs, targeting T helper type 2 (Th2) cytokines and IgE, have been developed and used for AD treatment [12], protein drugs are relatively expensive, and are restricted in their long-term use as anti-drug antibody production reduces their efficacy [13,14].